About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Rollover Protocol for Prior SU011248 Protocols

NCT00798889·59 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Pfizer

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Prior SU011248 Protocol.
Eligible to continue SU011248 treatment.

You may not be if

Uncontrolled CNS metastasis.
Unfit to receive SU011248.

The record

StatusCompleted

PhaseNo phase

Taking part314

StartedMar 2004

UpdatedJan 21, 2013

Conditions

Where59

Pfizer Investigational Site
Birmingham, Alabama, United States
Pfizer Investigational Site
Birmingham, Alabama, United States
Pfizer Investigational Site
Birmingham, Alabama, United States

Clareo Health | Rollover Protocol for Prior SU011248 Protocols